Summary
Mitochondria and the nucleus play critical roles in cell death. The signaling between these two organelles is dynamic. Understanding the signaling process between the nucleus and the mitochondria in cell death programs could lead us to more options in the development of new therapeutic targets. We discussed in this chapter how AIF could be released from the mitochondria and how AIF could act in PARP-dependent cell death mechanism. The molecular mechanisms accounting for PARP-dependent cell death are still being investigated but mitochondrial release of AIF and its translocation to the nucleus appears to be essential in this death process. We speculate that the PARP-mediated depletion of NAD and ATP or novel signals from PARP over activation might trigger AIF translocation; however, the authentic factors and the legitimate mechanism of mitochondrial AIF release remain to be explored.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Walker NI, Harmon BV, Gobe GC et al. Patterns of cell death. Methods Achiev Exp Pathol 1988; 13:18–54.
Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26(4):239–57.
Ravichandran KS. “Recruitment signals” from apoptotic cells: Invitation to a quiet meal. Cell 2003; 113(7):817–20.
Eliasson MJ, Sampei K, Mandir AS et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 1997; 3(10):1089–95.
Endres M, Wang ZQ, Namura S et al. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J Cereb Blood Flow Metab 1997; 17(11):1143–51.
Zhang J, Dawson VL, Dawson TM et al. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 1994; 263(5147):687–9.
Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408(6809):239–47.
Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001; 21(1):2–14.
Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: Cause, effect, or association? J Clin Invest 2003; 111(2):163–9.
Wood RD, Mitchell M, Sgouros J et al. Human DNA repair genes. Science 2001; 291(5507):1284–9.
Bernstein C, Bernstein H, Payne CM et al. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: Fail-safe protection against carcinogenesis. Mutat Res 2002; 511(2):145–78.
Bouchard VJ, Rouleau M, Poirier GG. PARP-1, a determinant of cell survival in response to DNA damage. Exp Hematol 2003; 31(6):446–54.
Virag L, Szabo C. The therapeutic potential of poly(ADP-Ribose) polymerase inhibitors. Pharmacol Rev 2002; 54(3):375–429.
Chiarugi A. Poly(ADP-ribose) polymerase: Killer or conspirator? The’ suicide hypothesis’ revisited. Trends Pharmacol Sci 2002; 23(3):122–9.
Gagne JP, Hunter JM, Labrecque B et al. A proteomic approach to the identification of heterogeneous nuclear ribonucleoproteins as a new family of poly(ADP-ribose)-binding proteins. Biochem J 2003; 371 (Pt 2):331–40.
Wang H, Shimoji M, Yu SW et al. Apoptosis inducing factor and PARP mediated injury in the MPTP mouse model of Parkinson’s disease: Ann N Y Acad Sci 2003; 991:132–9.
Kaminker PG, Kim SH, Taylor RD et al. TANK2, a new TRF1-associated poly(ADP-ribose) polymerase, causes rapid induction of cell death upon overexpression. J Biol Chem 2001; 276(38):35891–9.
Yu SW, Wang H, Poitras MF et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002; 297(5579):259–63.
Davidovic L, Vodenicharov M, Affar EB et al. Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism. Exp Cell Res 2001; 268(1):7–13.
Lin W, Ame JC, Aboul-Ela N et al. Isolation and characterization of the cDNA encoding bovine poly(ADP-ribose) glycohydrolase. J Biol Chem 1997; 272(18):11895–901.
Shimokawa T, Masutani M, Nagasawa S et al. Isolation and cloning of rat poly(ADP-ribose) glycohydrolase: Presence of a potential nuclear export signal conserved in mammalian orthologs. J Biochem (Tokyo) 1999; 126(4):748–55.
Ame JC, Apiou F, Jacobson EL et al. Assignment of the poly(ADP-ribose) glycohydrolase gene (PARG) to human chromosome 10q11.23 and mouse chromosome 14B by in situ hybridization. Cytogenet Cell Genet 1999; 85(3–4):269–70.
Ame JC, Jacobson EL, Jacobson MK. Molecular heterogeneity and regulation of poly(ADP-ribose) glycohydrolase. Mol Cell Biochem 1999; 193(1–2):75–81.
Ying W, Swanson RA. The poly(ADP-ribose) glycohydrolase inhibitor gallotannin blocks oxidative astrocyte death. Neuroreport 2000; 11(7):1385–8.
Perkins E, Sun D, Nguyen A et al. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Res 2001; 61(10):4175–83.
Jonsson GG, Jacobson EL, Jacobson MK. Mechanism of alteration of poly(adenosine diphosphate-ribose) metabolism by hyperthermia. Cancer Res 1988; 48(15):4233–9.
Hanai S, Kanai M, Ohashi S et al. Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proc Natl Acad Sci USA 2004; 101(1):82–6.
Susin SA, Lorenzo HK, Zamzami N et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397(6718):441–6.
Ye H, Cande C, Stephanou NC et al. DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol 2002; 9(9):680–4.
Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001; 412(6842):95–9.
Widlak P, Li LY, Wang X et al. Action of recombinant human apoptotic endonuclease G on naked DNA and chromatin substrates: Cooperation with exonuclease and DNase I. J Biol Chem 2001; 276(51):48404–9.
Lorenzo HK, Susin SA, Penninger J et al. Apoptosis inducing factor (AIF): A phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 1999; 6(6):516–24.
Mate MJ, Ortiz-Lombardia M, Boitel B et al. The crystal structure of the mouse apoptosis-inducing factor AIF. Nat Struct Biol 2002; 9(6):442–6.
Susin SA, Lorenzo HK, Zamzami N et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397(6718):441–6.
Daugas E, Susin SA, Zamzami N et al. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 2000; 14(5):729–39.
Lipton SA, Bossy-Wetzel E. Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Cell 2002; 111(2):147–50.
Klein JA, Longo-Guess CM, Rossmann MP et al. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature 2002; 419(6905):367–74.
Mate MJ, Ortiz-Lombardia M, Boitel B et al. The crystal structure of the mouse apoptosis-inducing factor AIF. Nat Struct Biol 2002; 9(6):442–6.
Joza N, Susin SA, Daugas E et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001; 410(6828):549–54.
Cregan SP, Fortin A, MacLaurin JG et al. Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol 2002; 158(3):507–17.
Susin SA, Daugas E, Ravagnan L et al. Two distinct pathways leading to nuclear apoptosis. J Exp Med 2000; 192(4):571–80.
Loeffler M, Daugas E, Susin SA et al. Dominant cell death induction by extramitochondrially targeted apoptosis-inducing factor. FASEB J 2001; 15(3):758–67.
Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science 2002; 297(5585):1352–4.
Robertson JD, Enoksson M, Suomela M et al. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J Biol Chem 2002; 277(33):29803–9.
Zamzami N, El Hamel C, Maisse C et al. Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene 2000; 19(54):6342–50.
Arnoult D, Gaume B, Karbowski M et al. Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 2003; 22(17):4385–4399.
Arnoult D, Parone P, Martinou JC et al. Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli. J Cell Biol 2002; 159(6):923–9.
Wang X, Yang C, Chai J et al. Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 2002; 298(5598):1587–92.
Hisatomi T, Sakamoto T, Goto Y et al. Critical role of photoreceptor apoptosis in functional damage after retinal detachment. Curr Eye Res 2002; 24(3):161–72.
Zhang X, Chen J, Graham SH et al. Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J Neurochem 2002; 82(1):181–91.
Zhu C, Qiu L, Wang X et al. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J Neurochem 2003; 86(2):306–17.
Braun JS, Novak R, Murray PJ et al. Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. J Infect Dis 2001; 184(10):1300–9.
Wang X, Zhu S, Drozda M et al. Minocycline inhibits caspase-independent and-dependent mitochondrial cell death pathways in models of Huntington’s disease. Proc Natl Acad Sci USA 2003.
Ravagnan L, Gurbuxani S, Susin SA et al. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol 2001; 3(9):839–43.
Ruchalski K, Mao H, Singh SK et al. HSP72 inhibits apoptosis-inducing factor release in ATP depleted renal epithelial cells. Am J Physiol Cell Physiol 2003.
Ly JD, Grubb DR, Lawen A. The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis 2003; 8(2):115–28.
Newmeyer DD, Ferguson-Miller S. Mitochondria: Releasing power for life and unleashing the machineries of death. Cell 2003; 112(4):481–90.
Loeffler M, Kroemer G. The mitochondrion in cell death control: Certainties and incognita. Exp Cell Res 2000; 256(1):19–26.
van Gurp M, Festjens N, van Loo G et al. Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 2003; 304(3):487–97.
Cheng EH, Sheiko TV, Fisher JK et al. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 2003; 301(5632):513–7.
Karbowski M, Lee YJ, Gaume B et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J Cell Biol 2002; 159(6):931–8.
Zamzami N, Kroemer G. The mitochondrion in apoptosis: How Pandora’s box opens. Nat Rev Mol Cell Biol 2001; 2(1):67–71.
D’Amours D, Desnoyers S, D’Silva I et al. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem J 1999; 342 (Pt 2):249–68.
Pleschke JM, Kleczkowska HE, Strohm M et al. Poly(ADP-ribose) binds to specific domains in DNA damage checkpoint proteins. J Biol Chem 2000; 275(52):40974–80.
Vaziri H, West MD, Allsopp RC et al. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J 1997; 16(19):6018–33.
Fan Z, Beresford PJ, Oh DY et al. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003; 112(5):659–72.
Mabley JG, Suarez-Pinzon WL, Hasko G et al. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes. Br J Pharmacol 2001; 133(6):909–19.
Suarez-Pinzon WL, Mabley JG, Power R et al. Poly (ADP-ribose) polymerase inhibition prevents spontaneous and recurrent autoimmune diabetes in NOD mice by inducing apoptosis of islet-infiltrating leukocytes. Diabetes 2003; 52(7):1683–8.
Pacher P, Liaudet L, Soriano FG et al. The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes 2002; 51(2):514–21.
Mandir AS, Poitras MF, Berliner AR et al. NMDA but not nonNMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase. J Neurosci 2000; 20(21):8005–11.
Cosi C, Colpaert F, Koek W et al. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57B1/6 mice. Brain Res 1996b; 729(2):264–9.
Cosi C, Chopin P, Marien M. Benzamide, an inhibitor of poly(ADP-ribose) polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57B1/6N mouse. Brain Res 1996a; 735(2):343–8.
Mandir AS, Przedborski S, Jackson-Lewis V et al. Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci USA 1999; 96(10):5774–9.
Wang H, Shimoji M, Yu SW et al. Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson’s disease. Ann N Y Acad Sci 2003; 991:132–9.
Cao G, Clark RS, Pei W et al. Translocation of apoptosis-inducing factor in vulnerable neurons after transient cerebral ischemia and in neuronal cultures after oxygen-glucose deprivation. J Cereb Blood Flow Metab 2003; 23(10):1137–50.
LaPlaca MC, Zhang J, Raghupathi R et al. Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. J Neurotrauma 2001; 18(4):369–76.
Suh SW, Aoyama K, Chen Y et al. Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J Neurosci 2003; 23(33):10681–90.
Scott GS, Jakeman LB, Stokes BT et al. Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury. Ann Neurol 1999; 45(1):120–4.
Cookson MR, Ince PG, Shaw PJ. Peroxynitrite and hydrogen peroxide induced cell death in the NSC34 neuroblastoma x spinal cord cell line: Role of poly (ADP-ribose) polymerase. J Neurochem 1998; 70(2):501–8.
Imai H, Koumura T, Nakajima R et al. Protection from inactivation of the adenine nucleotide translocator during hypoglycaemia-induced apoptosis by mitochondrial phospholipid hydroperoxide glutathione peroxidase. Biochem J 2003; 371(Pt 3):799–809.
Chiang SK, Lam TT. Post-treatment at 12 or 18 hours with 3-aminobenzamide ameliorates retinal ischemia-reperfusion damage. Invest Ophthalmol Vis Sci 2000; 41(10):3210–4.
Tabuchi K, Ito Z, Tsuji S et al. Poly(adenosine diphosphate-ribose) synthetase inhibitor 3-aminobenzamide alleviates cochlear dysfunction induced by transient ischemia. Ann Otol Rhinol Laryngol 2001; 110(2):118–21.
Jijon HB, Churchill T, Malfair D et al. Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol 2000; 279(3):G641–51.
Zingarelli B, O’Connor M, Hake PW. Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis. Eur J Pharmacol 2003; 469(1–3):183–94.
Koedel U, Winkler F, Angele B et al. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase. J Cereb Blood Flow Metab 2002; 22(1):39–49.
Braun JS, Sublett JE, Freyer D et al. Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis. J Clin Invest 2002; 109(1):19–27.
Miesel R, Kurpisz M, Kroger H. Modulation of inflammatory arthritis by inhibition of poly(ADP ribose) polymerase. Inflammation 1995; 19(3):379–87.
Rice WG, Schaeffer CA, Harten B et al. Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds. Nature 1993; 361(6411):473–5.
Ferri KF, Jacotot E, Blanco J et al. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex: Role of mitochondria and caspases. J Exp Med 2000; 192(8):1081–92.
Genini D, Sheeter D, Rought S et al. HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J 2001; 15(1):5–6.
Ha HC, Juluri K, Zhou Y et al. Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration. Proc Natl Acad Sci USA 2001; 98(6):3364–8.
Oliver FJ, Menissier-de Murcia J, Nacci C et al. Resistance to endotoxic shock as a consequence of defective NF-kappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO J 1999; 18(16):4446–54.
Veres B, Gallyas Jr F, Varbiro G et al. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol 2003; 65(8):1373–82.
Broaddus VC, Yang L, Scavo LM et al. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J Clin Invest 1996; 98(9):2050–9.
Ray SD, Balasubramanian G, Bagchi D et al. Ca(2+)-calmodulin antagonist chlorpromazine and poly(ADP-ribose) polymerase modulators 4-aminobenzamide and nicotinamide influence hepatic expression of BCL-XL and P53 and protect against acetaminophen-induced programmed and unprogrammed cell death in mice. Free Radic Biol Med 2001; 31(3):277–91.
Cuzzocrea S, McDonald MC, Mazzon E et al. Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury. Biochem Pharmacol 2002; 63(2):293–304.
Fujita T, Maruyama M, Araya J et al. Hydrogen peroxide induces upregulation of Fas in human airway epithelial cells via the activation of PARP-p53 pathway. Am J Respir Cell Mol Biol 2002; 27(5):542–52.
Liaudet L, Szabo E, Timashpolsky L et al. Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: Long-term morphological and functional consequences. Br J Pharmacol 2001; 133(8):1424–30.
Pieper AA, Walles T, Wei G et al. Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption. Mol Med 2000; 6(4):271–82.
Varbiro G, Toth A, Tapodi A et al. Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition. J Pharmacol Exp Ther 2003; 307(2):615–25.
Kim GT, Chun YS, Park JW et al. Role of apoptosis-inducing factor in myocardial cell death by ischemia-reperfusion. Biochem Biophys Res Commun 2003; 309(3):619–24.
Martin DR, Lewington AJ, Hammerman MR et al. Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am J Physiol Regul Integr Comp Physiol 2000; 279(5):R1834–40.
Ruchalski K, Mao H, Singh SK et al. HSP72 inhibits apoptosis-inducing factor release in ATP-depleted renal epithelial cells. Am J Physiol Cell Physiol 2003; 285(6):C1483–93.
Li F, Mao HP, Ruchalski KL et al. Heat stress prevents mitochondrial injury in ATP-depleted renal epithelial cells. Am J Physiol Cell Physiol 2002; 283(3):C917–26.
Rosenthal DS, Simbulan-Rosenthal CM, Liu WF et al. PARP determines the mode of cell death in skin fibroblasts, but not keratinocytes, exposed to sulfur mustard. J Invest Dermatol 2001; 117(6):1566–73.
Pardo J, Perez-Galan P, Gamen S et al. A role of the mitochondrial apoptosis-inducing factor in granulysin-induced apoptosis. J Immunol 2001; 167(3):1222–9.
Yamamoto T, Ueta E, Osaki T. Apoptosis induction by interleukin-2-activated cytotoxic lymphocytes in a squamous cell carcinoma cell line and Daudi cells-involvement of reactive oxygen species-dependent cytochrome c and reactive oxygen species-independent apoptosis-inducing factors. Immunology 2003; 110(2):217–24.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Hong, S.J., Dawson, T.M., Dawson, V.L. (2006). PARP and the Release of Apoptosis-Inducing Factor from Mitochondria. In: Poly(ADP-Ribosyl)ation. Molecular Biology Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/0-387-36005-0_10
Download citation
DOI: https://doi.org/10.1007/0-387-36005-0_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-33371-7
Online ISBN: 978-0-387-36005-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)